More excitingly, AubipyOMe evidently reversed established pulmonary fibrosis in a dose depend manner without toxic effects on mice, further suggesting the therapeutic potential of targeting Acp5 on pulmonary fibrosis in clinical practice. The gene discussed is ACP5; the disease is pulmonary fibrosis.